Filana Therapeutics, Inc. Depreciation
Filana Therapeutics, Inc. (FLNA) reported Depreciation of $243.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-05-07
- Filana Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $243.00K, a 10.45% increase year-over-year.
- Filana Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $334.00K, a 317.50% increase year-over-year.
- Filana Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $200.00K, a 0.00% change year-over-year.
- Filana Therapeutics, Inc. depreciation for the quarter ending 2025-06-30 was $200.00K, a 33.33% decline year-over-year.
- Filana Therapeutics, Inc. depreciation for fiscal 2025 was $903.00K, a 5.15% decline from fiscal 2024.
- Filana Therapeutics, Inc. depreciation for fiscal 2024 was $952.00K, a 12.18% decline from fiscal 2023.
- Filana Therapeutics, Inc. depreciation for fiscal 2023 was $1.08M, a 34.83% increase from fiscal 2022.
- Filana Therapeutics, Inc. depreciation for fiscal 2022 was $804.00K, a 159.35% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $243.00K 10-Q · filed 2026-05-07 | $577.00K derived: sum of 2 quarters · filed 2026-05-07 | $777.00K derived: sum of 3 quarters · filed 2026-05-07 | $977.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2025-12-31 | $334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $534.00K derived: sum of 2 quarters · filed 2026-03-12 | $734.00K derived: sum of 3 quarters · filed 2026-03-12 | $903.00K 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-12 | $400.00K derived: sum of 2 quarters · filed 2025-11-12 | $569.00K 10-Q · filed 2025-11-12 | $700.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2025-06-30 | $200.00K 10-Q · filed 2025-08-14 | $438.00K 10-Q · filed 2025-08-14 | $500.00K derived: sum of 3 quarters · filed 2026-05-07 | $700.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2025-03-31 | $220.00K 10-Q · filed 2026-05-07 | $300.00K derived: sum of 2 quarters · filed 2026-05-07 | $500.00K derived: sum of 3 quarters · filed 2026-05-07 | $800.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $280.00K derived: sum of 2 quarters · filed 2026-03-12 | $580.00K derived: sum of 3 quarters · filed 2026-03-12 | $952.00K 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-12 | $228.00K 10-Q · filed 2024-11-07 | $500.00K derived: sum of 2 quarters · filed 2025-11-12 | $872.00K 10-Q · filed 2025-11-12 | $724.00K 10-Q · filed 2024-11-07 | $1.08M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-14 | $244.00K 10-Q · filed 2024-08-08 | $613.00K 10-Q · filed 2025-08-14 | $496.00K 10-Q · filed 2024-08-08 | $878.00K derived: sum of 3 quarters · filed 2026-03-12 | $1.15M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-03-31 | $311.00K 10-Q · filed 2025-05-08 | $250.00K 10-Q · filed 2024-05-10 | $578.00K derived: sum of 2 quarters · filed 2026-03-12 | $851.00K derived: sum of 3 quarters · filed 2026-03-12 | $1.12M derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2023-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $540.00K derived: sum of 2 quarters · filed 2026-03-12 | $812.00K derived: sum of 3 quarters · filed 2026-03-12 | $1.08M 10-K · filed 2026-03-12 | |||
| 2023-09-30 | $273.00K 10-Q · filed 2024-11-07 | $545.00K derived: sum of 2 quarters · filed 2024-11-07 | $817.00K 10-Q · filed 2024-11-07 | $1.09M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-06-30 | $272.00K 10-Q · filed 2024-08-08 | $544.00K 10-Q · filed 2024-08-08 | $815.00K derived: sum of 3 quarters · filed 2025-03-03 | $996.00K derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-03-31 | $272.00K 10-Q · filed 2024-05-10 | $543.00K derived: sum of 2 quarters · filed 2025-03-03 | $724.00K derived: sum of 3 quarters · filed 2025-03-03 | $898.00K derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2022-12-31 | $271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $452.00K derived: sum of 2 quarters · filed 2025-03-03 | $626.00K derived: sum of 3 quarters · filed 2025-03-03 | $804.00K 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $181.00K 10-Q · filed 2023-11-07 | $355.00K derived: sum of 2 quarters · filed 2023-11-07 | $533.00K 10-Q · filed 2023-11-07 | $712.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | $174.00K 10-Q · filed 2023-08-03 | $352.00K 10-Q · filed 2023-08-03 | $531.00K derived: sum of 3 quarters · filed 2024-02-28 | $652.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | $178.00K 10-Q · filed 2023-05-01 | $357.00K derived: sum of 2 quarters · filed 2024-02-28 | $478.00K derived: sum of 3 quarters · filed 2024-02-28 | $486.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $300.00K derived: sum of 2 quarters · filed 2024-02-28 | $308.00K derived: sum of 3 quarters · filed 2024-02-28 | $310.00K 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $121.00K 10-Q · filed 2022-11-07 | $129.00K derived: sum of 2 quarters · filed 2022-11-07 | $131.00K 10-Q · filed 2022-11-07 | $131.00K derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $8.00K 10-Q · filed 2022-08-04 | $9.00K 10-Q · filed 2022-08-04 | $10.00K derived: sum of 3 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-05 | $2.00K derived: sum of 2 quarters · filed 2023-02-28 | |||||
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $22.00K 10-K · filed 2023-02-28 | |||||
| 2020-09-30 | $21.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |